• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠康复患者自然感染6个月后SARS-CoV-2-IgG抗体持久性

Persistence of SARS-CoV-2-IgG antibody durability in convalescent COVID-19 patients 6 months after the natural infection.

作者信息

Hua Qiaoli, Zhang Peng, Qin Shengle, Feng Bing, Xiao Bin, Zheng Guangjuan, Ye Taoyu, Zheng Danwen, Mo Jiayi, Liu Yuntao, Cai Yun, Xu Xiaohua, Hu Ji, Ding Banghan, Li Yingrui, Guo Jianwen, Wang Jun, Cao Hongzhi, Zhang Zhongde

机构信息

Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.

iCarbonX (Zhuhai) Company Limited, Zhuhai, China.

出版信息

Front Med (Lausanne). 2025 Aug 11;12:1623509. doi: 10.3389/fmed.2025.1623509. eCollection 2025.

DOI:10.3389/fmed.2025.1623509
PMID:40861223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12375572/
Abstract

INTRODUCTION

Long-term SARS-CoV-2-IgG antibody durability after natural infection remains a critical determinant of long-term protection. However, the factors that affect long-term IgG antibody durability are not fully understood.

METHODS

This study delves into the clinical and host genetic factors influencing the level of long-term anti-SARS-CoV-2-receptor-binding domain IgG (RBD-IgG) antibodies after natural infection during the first wave of the COVID-19 pandemic (17 January to 24 June 2020). The cohort, comprising 572 COVID-19 patients from Wuhan, China, had no exposure to COVID-19 vaccines, variants, or antiviral treatments, enabling a focused analysis of the virus's direct impact.

RESULTS

We found that the rate of RBD-IgG seropositivity 6 months after infection remained high (94.58%). Through a generalized linear model and mediation analysis, older age, independent of disease severity, was found to be a key independent factor associated with higher post-infection RBD-IgG titers. Hypothesis-generating analyses through a genome-wide association study revealed that rs117929853 ( = 3.6 × 10), a variant located upstream of the , was significantly associated with RBD-IgG persistence, suggesting a potential mechanistic link between polymorphisms and sustained humoral immunity.

CONCLUSION

The study underscores the significant role of age and genetic factors in the pathogenesis of sustained humoral immunity, which requires further validation.

摘要

引言

自然感染后严重急性呼吸综合征冠状病毒2(SARS-CoV-2)IgG抗体的长期耐久性仍然是长期保护的关键决定因素。然而,影响IgG抗体长期耐久性的因素尚未完全明确。

方法

本研究深入探讨了在2019冠状病毒病(COVID-19)大流行第一波期间(2020年1月17日至6月24日)自然感染后影响长期抗SARS-CoV-2受体结合域IgG(RBD-IgG)抗体水平的临床和宿主遗传因素。该队列由来自中国武汉的572例COVID-19患者组成,未接触过COVID-19疫苗、变异株或抗病毒治疗,从而能够重点分析病毒的直接影响。

结果

我们发现感染后6个月RBD-IgG血清阳性率仍然很高(94.58%)。通过广义线性模型和中介分析,发现年龄较大是与感染后RBD-IgG滴度较高相关的关键独立因素,与疾病严重程度无关。通过全基因组关联研究进行的假设生成分析显示,位于基因上游的rs117929853(=3.6×10)与RBD-IgG的持久性显著相关,提示基因多态性与持续体液免疫之间可能存在机制联系。

结论

该研究强调了年龄和遗传因素在持续体液免疫发病机制中的重要作用,这需要进一步验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf96/12375572/2134ecf33d90/fmed-12-1623509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf96/12375572/3ea1d5f76af6/fmed-12-1623509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf96/12375572/42e468e1fea9/fmed-12-1623509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf96/12375572/2134ecf33d90/fmed-12-1623509-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf96/12375572/3ea1d5f76af6/fmed-12-1623509-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf96/12375572/42e468e1fea9/fmed-12-1623509-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf96/12375572/2134ecf33d90/fmed-12-1623509-g003.jpg

相似文献

1
Persistence of SARS-CoV-2-IgG antibody durability in convalescent COVID-19 patients 6 months after the natural infection.新冠康复患者自然感染6个月后SARS-CoV-2-IgG抗体持久性
Front Med (Lausanne). 2025 Aug 11;12:1623509. doi: 10.3389/fmed.2025.1623509. eCollection 2025.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
COVID-19 Vaccines2019冠状病毒病疫苗
4
Anti-SARS-CoV-2 total immunoglobulin and neutralising antibody responses in healthy blood donors throughout the COVID-19 pandemic: a longitudinal observational study.在整个 COVID-19 大流行期间健康献血者的抗 SARS-CoV-2 总免疫球蛋白和中和抗体反应:一项纵向观察研究。
Swiss Med Wkly. 2024 Jul 1;154:3408. doi: 10.57187/s.3408.
5
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2.早期使用康复期血浆治疗新冠病毒病对严重急性呼吸综合征冠状病毒2抗体反应的影响。
Microbiol Spectr. 2025 Jul;13(7):e0300624. doi: 10.1128/spectrum.03006-24. Epub 2025 Jun 9.
6
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
7
Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: A prospective cohort study.加拿大医护人员中 SARS-CoV-2 IgG 反应和衰减的决定因素:一项前瞻性队列研究。
Vaccine. 2024 Feb 15;42(5):1168-1178. doi: 10.1016/j.vaccine.2024.01.052. Epub 2024 Jan 25.
8
Hyperimmune immunoglobulin for people with COVID-19.COVID-19 免疫球蛋白
Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD015167. doi: 10.1002/14651858.CD015167.pub2.
9
Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group.新冠康复组的肺功能及SARS-CoV-2受体结合域特异性IgG抗体反应比较
PLoS One. 2025 Jul 11;20(7):e0318959. doi: 10.1371/journal.pone.0318959. eCollection 2025.
10
Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate Analysis.使用单份分析在一种地诺单抗生物类似药候选产品的临床研究中评估抗SARS-CoV-2 IgG反应。
Drugs R D. 2025 May 23. doi: 10.1007/s40268-025-00510-z.

本文引用的文献

1
Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination.季节性冠状病毒免疫印迹对灭活 COVID-19 疫苗免疫原性的影响。
Front Immunol. 2023 Aug 16;14:1195533. doi: 10.3389/fimmu.2023.1195533. eCollection 2023.
2
Metal-induced oxidative stress and human plasma protein oxidation after SARS-CoV-2 infection.金属诱导的氧化应激和 SARS-CoV-2 感染后的人血浆蛋白氧化。
Sci Rep. 2023 Feb 10;13(1):2441. doi: 10.1038/s41598-023-29119-5.
3
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
SARS-CoV-2 特异性鼻内 IgA 在 COVID-19 住院治疗 9 个月后消失,且不会因后续接种疫苗而产生。
EBioMedicine. 2023 Jan;87:104402. doi: 10.1016/j.ebiom.2022.104402. Epub 2022 Dec 19.
4
SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions.SARS-CoV-2 抗体在非医疗接触密集型职业的健康员工自然感染后可持续长达 12 个月。
Int J Infect Dis. 2023 Jan;126:155-163. doi: 10.1016/j.ijid.2022.11.025. Epub 2022 Nov 24.
5
Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.影响医护人员抗 SARS-CoV-2 刺突 IgG 抗体效价的因素:一项横断面研究。
J Med Virol. 2023 Jan;95(1):e28300. doi: 10.1002/jmv.28300. Epub 2022 Nov 18.
6
Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4-13 Months after COVID-19.新型冠状病毒肺炎感染后4至13个月时针对严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域的抗体
J Clin Med. 2022 Jul 13;11(14):4053. doi: 10.3390/jcm11144053.
7
Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections.接种疫苗者突破性感染德尔塔 SARS-CoV-2 的临床特征和免疫谱改变。
Nat Commun. 2022 Jul 9;13(1):3979. doi: 10.1038/s41467-022-31693-7.
8
Evolutionary impacts of purine metabolism genes on mammalian oxidative stress adaptation.嘌呤代谢基因对哺乳动物氧化应激适应的进化影响。
Zool Res. 2022 Mar 18;43(2):241-254. doi: 10.24272/j.issn.2095-8137.2021.420.
9
Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.具有有限的新冠病毒交叉反应性的季节性冠状病毒特异性B细胞在重症新冠病毒肺炎中主导IgG反应。
J Clin Invest. 2021 Nov 1;131(21). doi: 10.1172/JCI150613.
10
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.黄嘌呤脱氢酶作为肝细胞癌中与肿瘤免疫学相关的预后生物标志物。
Cancer Cell Int. 2021 Sep 8;21(1):475. doi: 10.1186/s12935-021-02173-7.